AI
CPRX

AdvisorShares Investments’s Catalyst Pharmaceutical CPRX Stock Holding History

AdvisorShares Investments’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-36,100
Closed -$299K – 246
2022
Q1 		$299K Buy
+36,100
New +$255K 0.05% 136

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AdvisorShares Investments's CPRX Position: Q2 2022 in Review

AdvisorShares Investments sold out of Catalyst Pharmaceutical (CPRX) in Q2 2022, closing a stake of 36,100 shares — an estimated $299K sold.

AdvisorShares Investments first reported a position in CPRX in Q1 2022 and held it in 1 quarter. The position peaked at $299K in Q1 2022. 189 funds tracked by Wall St. Rank hold CPRX as of Q2 2022.

  • AdvisorShares Investments reported no remaining Catalyst Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • AdvisorShares Investments sold 36,100 Catalyst Pharmaceutical shares in Q2 2022, an estimated $299K.
  • AdvisorShares Investments first reported a position in Catalyst Pharmaceutical in Q1 2022 and held it in 1 quarter.
  • AdvisorShares Investments's Catalyst Pharmaceutical position peaked at $299K in Q1 2022.
  • 189 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2022.

Based on AdvisorShares Investments's 13F filing for Q2 2022, filed 8 Aug 2022.